BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25927411)

  • 21. Novel and highly sensitive mixed-polymeric electrokinetic chromatography system for determination of contaminants and impurities of heparin samples.
    Tripodi V; Flor S; Dobrecky C; Contin M; Lucangioli S
    Electrophoresis; 2010 Oct; 31(21):3606-12. PubMed ID: 20967770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative capillary electrophoresis determination of oversulfated chondroitin sulfate as a contaminant in heparin preparations.
    Volpi N; Maccari F; Linhardt RJ
    Anal Biochem; 2009 May; 388(1):140-5. PubMed ID: 19232311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products.
    Bairstow S; McKee J; Nordhaus M; Johnson R
    Anal Biochem; 2009 May; 388(2):317-21. PubMed ID: 19289093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Ca2+ on the 1H NMR chemical shift of the methyl signal of oversulphated chondroitin sulphate, a contaminant in heparin.
    McEwen I; Rundlöf T; Ek M; Hakkarainen B; Carlin G; Arvidsson T
    J Pharm Biomed Anal; 2009 Apr; 49(3):816-9. PubMed ID: 19179033
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.
    Li B; Suwan J; Martin JG; Zhang F; Zhang Z; Hoppensteadt D; Clark M; Fareed J; Linhardt RJ
    Biochem Pharmacol; 2009 Aug; 78(3):292-300. PubMed ID: 19389385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thymine-based molecular beacon for sensing adenosine based on the inhibition of S-adenosylhomocysteine hydrolase activity.
    Nieh CC; Tseng WL
    Biosens Bioelectron; 2014 Nov; 61():404-9. PubMed ID: 24914852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of possible economically motivated adulterants in heparin sodium and low molecular weight heparins with a colorimetric microplate based assay.
    Sommers CD; Keire DA
    Anal Chem; 2011 Sep; 83(18):7102-8. PubMed ID: 21819047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of high-charge density polyanion contaminants in biomedical heparin preparations using potentiometric polyanion sensors.
    Wang L; Buchanan S; Meyerhoff ME
    Anal Chem; 2008 Dec; 80(24):9845-7. PubMed ID: 19007240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure elucidation and biological activity of the oversulfated chondroitin sulfate contaminant in Baxter heparin.
    McKee J; Bairstow S; Szabo C; Ray J; Wielgos T; Hu P; Chess E; Nordhaus M; Hai T; Campbell J; Donovan S; Viseux N; Riedel N; Cammack J; Johnson R
    J Clin Pharmacol; 2010 Oct; 50(10):1159-70. PubMed ID: 20147614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Composition of OSCS-contaminated heparin occurring in 2008 in batches on the German market.
    Beyer T; Matz M; Brinz D; Rädler O; Wolf B; Norwig J; Baumann K; Alban S; Holzgrabe U
    Eur J Pharm Sci; 2010 Jul; 40(4):297-304. PubMed ID: 20399266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and Application of Nanosensor in Safeguarding Heparin Supply Chain.
    Bi Y; Le KD; Ramamoorthy G; Kuberan B
    SLAS Technol; 2020 Aug; 25(4):397-403. PubMed ID: 32589074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oversulfated chondroitin sulfate inhibits the complement classical pathway by potentiating C1 inhibitor.
    Zhou ZH; Rajabi M; Chen T; Karnaukhova E; Kozlowski S
    PLoS One; 2012; 7(10):e47296. PubMed ID: 23077587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of established and novel purity tests for the quality control of heparin by means of a set of 177 heparin samples.
    Alban S; Lühn S; Schiemann S; Beyer T; Norwig J; Schilling C; Rädler O; Wolf B; Matz M; Baumann K; Holzgrabe U
    Anal Bioanal Chem; 2011 Jan; 399(2):605-20. PubMed ID: 20824424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dimer-promoted fluorescence quenching of coralyne by binding to anionic polysaccharides.
    Megyesi M; Biczók L; Görner H
    Photochem Photobiol Sci; 2009 Apr; 8(4):556-61. PubMed ID: 19337671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of contaminants in recalled unfractionated heparin and low-molecular-weight heparin.
    Viskov C; Bouley E; Hubert P; Martinez C; Herman F; Jeske W; Hoppensteadt D; Walenga JM; Fareed J
    Clin Appl Thromb Hemost; 2009; 15(4):395-401. PubMed ID: 19617248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of crude heparin by (1)H NMR, capillary electrophoresis, and strong-anion-exchange-HPLC for contamination by over sulfated chondroitin sulfate.
    Keire DA; Trehy ML; Reepmeyer JC; Kolinski RE; Ye W; Dunn J; Westenberger BJ; Buhse LF
    J Pharm Biomed Anal; 2010 Mar; 51(4):921-6. PubMed ID: 19959313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
    Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
    Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiplexed DNA detection with a composite molecular beacon based on guanine-quenching.
    Xiang DS; Zhai K; Wang LZ
    Analyst; 2013 Sep; 138(18):5318-24. PubMed ID: 23869386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-sensitivity visualisation of contaminants in heparin samples by spectral filtering of 1H NMR spectra.
    Rudd TR; Gaudesi D; Lima MA; Skidmore MA; Mulloy B; Torri G; Nader HB; Guerrini M; Yates EA
    Analyst; 2011 Apr; 136(7):1390-8. PubMed ID: 21279244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.